COVID Resources - POCTRN
COVID-19 Resources
A curated list of the latest COVID-19 information such as federal agency guidance, funding opportunities, and resources for researchers.
Funding Opportunities
NIH
- Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
- Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network
- Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
- Flexibilities Available to AHRQ Recipients and Applicants Directly Impacted by the Novel Coronavirus (COVID-19) Due to Loss of Operations
- Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)
- Administrative Supplement
- Notice of Special Interest regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
- Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
- Notice of Special Interest regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
- Notice of Special Interest: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
- Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
- Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- Notice of Special Interest: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
- Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
- Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA
- Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
- Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
- NCATS Opportunities
DOD
Department of Energy
NSF
- NSF Rapid Research on Coronavirus (COVID-19) for U.S. institutions
- Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
BARDA
- 2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
US International Development Finance Corporation (DFC)
Wellcome Trust, the Bill and Melinda Gates Foundation and Mastercard
FDA Emergency Guidance
- FDA Guidance on Emergency Authorization
- FDA COVID-19 Emergency Use Authorizations for In Vitro Diagnostics
- FDA COVID-19 Emergency Use Authorizations for High Complexity Molecular-Based Laboratory Developed Tests
- FDA COVID-19 Emergency Use Authorizations for Personal Protective Equipment
- FDA COVID-19 Emergency Use Authorizations for Ventilators and other Medical Devices
- FDA COVID-19 Emergency Use Authorizations for Therapeutics
NIH Guidance, Resources, Training, and Updates
- LitCovid
- NIBIB Response to COVID-19
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
- Roundup of New COVID-19 Resources for NIH Applicants and Recipients: Part 2
- NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool
- NIH COVID-19 Resources and News Releases
- Open-Access Data and Computational Resources to Address COVID-19
- NCBI Virus’ COVID-19 data hub
- GenBank COVID-19 Sequences
- COVID-19 Clinical Trials
- Coronaviruses
- Coronavirus Resources
- Coronavirus news and resources for global health researchers
- NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
- Training resources for coronavirus workers dealing with the spread of COVID-19
CDC Guidance and Resources
- Guidance for Healthcare Professionals
- COVID-19 (2019 Novel Coronavirus) Research Guide
- Research Articles Downloadable Database
- Secondary data and statistics sources to help researchers find data on COVID-19
- Centers for Disease Control and Prevention’s Situation Summary
- Public Health Genomics and Precision Health Knowledge Base (v6.2.2)